bioAffinity Technologies, Inc. (BIAFW) stock

BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value

$0.24+0.00 (0.00%)

Close on Oct 30, 2026Market cap $23.58MP/E –Yield –

bioAffinity Technologies price to free cash flow

Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.

bioAffinity Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in bioAffinity Technologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on Aug 24, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIAFW.

Revenue growth-23.2% · median 15.4%

Operating margin-209.8% · median -125.2%

Net margin-257.3% · median -111.4%

Advertisement
300 × 250